Advertisement
Table 2 Characteristics of treatments
| Number of Patients | |
|---|---|
| Breath control techniques | |
| Gating | 20 |
| Active breathing control | 7 |
| Free Breathing | 4 |
| Prescriptions | |
| 5–7.5 GyE X 8–10 Fx | 12 |
| 4–5 GyE X 15–16 Fx | 3 |
| 2.25–3.5 GyE X 22–31 Fx | 16 |
| BED10 (GyE), median (range) | 96 (75–119) |
| Radiation techniques/sources | |
| PRT only | 6 |
| PRT + CIRT boost | 6 |
| CIRT only | 19a |
| Chemotherapy | 6 |
| 1 cycle (neoadjuvant of pemetrexed+ cisplatin) | 1 |
| 3 cycles (concurrent of Taxol+ cisplatin) | 1 |
| 4 cycles (neoadjuvant of etoposide+ cisplatin) | 1 |
| 4 cycles (neoadjuvant of pemetrexed X 3+ docetaxel X 1) | 1 |
| 5 cycles (neoadjuvant of gemcitabine+ cisplatin X 3 + concurrent of Taxol+ cisplatin X 2) | 1 |
| 6 cycles (neoadjuvant of gemcitabine+ cisplatin) | 1 |
